2022 Credit Outlook - U.S. Healthcare and Pharma Outlook Neutral for 2022
1:07
The 2022 sector outlooks for U.S. healthcare and pharma companies is neutral, as healthcare demand should remain durable and headwinds to profitability should be manageable.